Beijing Olympics Deal A Blow To Indian Drug Makers As API Prices Rise
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - Indian drug makers are faced with a severe shortage of key active pharmaceutical ingredients as the Chinese government clamps down on the manufacture and movement of chemicals known to pollute the environment. As such, exports of known hazardous chemicals and APIs to India from China have dried up leading to shortage and a spurt in raw material prices